The investigators propose a pilot clinical trial on the use of perioperative pregabalin in
order to decrease ureteral stent related symptoms and decrease opioid usage after
ureteroscopy with stent placement. Patients undergoing ureteroscopy with stent placement will
receive a single dose of 300 mg pregabalin PO in the preoperative area. This work will assess
safety and feasibility of studying this regimen at our institution, with the aim of
performing a randomized, placebo-controlled, double-blinded study in the future.